AmerisourceBergen & Trakcel launch integrated platform for gene therapies
European Pharmaceutical Manufacturer, Willis Chandler
A new integrated technology platform has been launched to help accelerate patient access to prescribed cell and gene therapies. The platform has been launched by healthcare solutions provider AmerisourceBergen and cellular orchestration solutions leader TrakCel. Besides accelerating patient access to cell and gene therapies, the platform also aims to deliver complete visibility throughout a patient’s treatment journey.
For the full article, please visit European Pharmaceutical Manufacturer.
Cencora.com is providing automated translations to assist in reading the website in languages other than English. For these translations, reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace human translators. These translations are provided as a service to users of Cencora.com and are provided "as is." No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, or correctness of any of these translations made from English into any other language. Some content (such as images, videos, Flash, etc.) may not be accurately translated due to the limitations of the translation software.
Any discrepancies or differences created in translating this content from English into another language are not binding and have no legal effect for compliance, enforcement, or any other purpose. If any errors are identified, please contact us. If any questions arise related to the accuracy of the information contained in these translations, please refer to the English version of the page.